CD99 and glioma: A recent bioinformatic analysis from multiple gliomas datasets highlighted an association of CD99 overexpression with tumor hypoxia, angiogenesis, epithelial-mesenchymal transition, metabolic reprogramming, and an immunosuppressive microenvironment dominated by M2 tumor-associated macrophages [26].